Wayde McMillan

Executive Vice President, Chief Financial Officer (Principal Financial Officer), Solventum Corp

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Wayde McMillan signed the annual report of Solventum Corp as Executive Vice President, Chief Financial Officer (Principal Financial Officer); the report was filed on February 27, 2026, the most recent filing in the record that ties Wayde McMillan to the seat.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Solventum Corp (SOLV) Surgical & Medical Instruments & Apparatus	Executive Vice President, Chief Financial Officer (Principal Financial Officer)	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

February 27, 202610-K filed
Wayde McMillan signed the annual report of Solventum Corp on Form 10-K as Executive Vice President, Chief Financial Officer (Principal Financial Officer), filed February 27, 2026.
/s/ Wayde McMillan Wayde McMillan, Executive Vice President, Chief Financial Officer (Principal Financial Officer)
[1] Annual report on Form 10-K by Solventum Corp, filed with the SEC on February 27, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, Solventum Corp. U.S. Securities and Exchange Commission, EDGAR, filed February 27, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Wayde McMillan wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.